Does the media refer more to COO or XRAY?

In the previous week, Cooper Companies had 59 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 64 mentions for Cooper Companies and 5 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Cooper Companies' score of 0.33 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 14 Very Positive mention(s) 6 Positive mention(s) 20 Neutral mention(s) 9 Negative mention(s) 4 Very Negative mention(s) Neutral DENTSPLY SIRONA 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor XRAY or MMSI?

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 5 articles in the media. Merit Medical Systems' average media sentiment score of 1.56 beat DENTSPLY SIRONA's score of 1.13 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to XRAY or NVST?

In the previous week, Envista had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 7 mentions for Envista and 5 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Envista's score of 0.64 indicating that DENTSPLY SIRONA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BLCO or XRAY?

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 5 mentions for DENTSPLY SIRONA and 4 mentions for Bausch + Lomb. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Bausch + Lomb's score of -0.04 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch + Lomb 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DENTSPLY SIRONA 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to XRAY or ICUI?

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 5 articles in the media. ICU Medical's average media sentiment score of 1.26 beat DENTSPLY SIRONA's score of 1.13 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

DENTSPLY SIRONA (XRAY) Competitors

$10.50 -0.22 (-2.05%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$10.58 +0.08 (+0.80%)

As of 04:58 AM Eastern

Compare

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

Should you buy DENTSPLY SIRONA stock or one of its competitors? DENTSPLY SIRONA's main competitors and comparable companies include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), Bausch + Lomb (BLCO), and ICU Medical (ICUI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does DENTSPLY SIRONA compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Cooper Companies has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, indicating that its stock price is 16% less volatile than the broader market.

Cooper Companies has a net margin of 13.46% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	13.46%	10.92%	7.27%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 59 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 64 mentions for Cooper Companies and 5 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Cooper Companies' score of 0.33 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	14 Very Positive mention(s)	6 Positive mention(s)	20 Neutral mention(s)	9 Negative mention(s)	4 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cooper Companies presently has a consensus price target of $71.47, indicating a potential upside of 31.93%. DENTSPLY SIRONA has a consensus price target of $13.54, indicating a potential upside of 28.94%. Given Cooper Companies' stronger consensus rating and higher possible upside, equities analysts plainly believe Cooper Companies is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	2 Sell rating(s)	11 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.17
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	2.58	$374.90M	$1.18	45.91
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$2.75	N/A

Summary

Cooper Companies beats DENTSPLY SIRONA on 12 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

DENTSPLY SIRONA (NASDAQ:XRAY) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Merit Medical Systems has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$2.75	N/A
Merit Medical Systems	$1.52B	3.41	$128.49M	$2.42	35.73

DENTSPLY SIRONA presently has a consensus target price of $13.54, suggesting a potential upside of 28.94%. Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 15.65%. Given DENTSPLY SIRONA's higher probable upside, equities research analysts plainly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DENTSPLY SIRONA has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.49, suggesting that its stock price is 51% less volatile than the broader market.

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 5 articles in the media. Merit Medical Systems' average media sentiment score of 1.56 beat DENTSPLY SIRONA's score of 1.13 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Merit Medical Systems has a net margin of 9.22% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Merit Medical Systems	9.22%	13.75%	8.10%

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 12 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

DENTSPLY SIRONA has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$2.75	N/A
Envista	$2.72B	1.52	$47M	$0.58	44.50

In the previous week, Envista had 2 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 7 mentions for Envista and 5 mentions for DENTSPLY SIRONA. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Envista's score of 0.64 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a net margin of 3.33% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
Envista	3.33%	7.88%	4.33%

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DENTSPLY SIRONA presently has a consensus price target of $13.54, indicating a potential upside of 28.94%. Envista has a consensus price target of $29.71, indicating a potential upside of 15.13%. Given DENTSPLY SIRONA's higher possible upside, equities research analysts plainly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.56

Summary

Envista beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

Bausch + Lomb has higher revenue and earnings than DENTSPLY SIRONA. Bausch + Lomb is trading at a lower price-to-earnings ratio than DENTSPLY SIRONA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$5.10B	1.23	-$360M	-$0.48	N/A
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$2.75	N/A

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, DENTSPLY SIRONA had 1 more articles in the media than Bausch + Lomb. MarketBeat recorded 5 mentions for DENTSPLY SIRONA and 4 mentions for Bausch + Lomb. DENTSPLY SIRONA's average media sentiment score of 1.13 beat Bausch + Lomb's score of -0.04 indicating that DENTSPLY SIRONA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch + Lomb	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bausch + Lomb currently has a consensus price target of $19.15, suggesting a potential upside of 8.94%. DENTSPLY SIRONA has a consensus price target of $13.54, suggesting a potential upside of 28.94%. Given DENTSPLY SIRONA's higher possible upside, analysts plainly believe DENTSPLY SIRONA is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bausch + Lomb has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market.

Bausch + Lomb has a net margin of -3.21% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat Bausch + Lomb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-3.21%	4.14%	1.93%
DENTSPLY SIRONA	-14.99%	20.84%	5.32%

Summary

Bausch + Lomb and DENTSPLY SIRONA tied by winning 8 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

DENTSPLY SIRONA (NASDAQ:XRAY) and ICU Medical (NASDAQ:ICUI) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership.

DENTSPLY SIRONA currently has a consensus target price of $13.54, indicating a potential upside of 28.94%. ICU Medical has a consensus target price of $192.80, indicating a potential upside of 22.60%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
ICU Medical	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.89

95.7% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, DENTSPLY SIRONA and DENTSPLY SIRONA both had 5 articles in the media. ICU Medical's average media sentiment score of 1.26 beat DENTSPLY SIRONA's score of 1.13 indicating that ICU Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ICU Medical	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DENTSPLY SIRONA has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market.

ICU Medical has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.57	-$598M	-$2.75	N/A
ICU Medical	$2.23B	1.76	$730K	$1.18	133.27

ICU Medical has a net margin of 1.39% compared to DENTSPLY SIRONA's net margin of -14.99%. DENTSPLY SIRONA's return on equity of 20.84% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-14.99%	20.84%	5.32%
ICU Medical	1.39%	7.91%	4.17%

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 16 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.14B	$5.58B	$7.21B	$12.81B
Dividend Yield	N/A	1.78%	2.56%	10.55%
P/E Ratio	-3.82	24.44	272.83	25.11
Price / Sales	0.57	72.50	623.31	90.53
Price / Cash	1.79	32.69	77.33	51.83
Price / Book	1.56	5.89	10.38	6.18
Net Income	-$598M	$150.94M	$3.49B	$358.18M
7 Day Performance	-7.73%	-3.04%	-3.16%	-2.51%
1 Month Performance	-9.56%	-3.90%	0.02%	-2.73%
1 Year Performance	-24.68%	5.59%	17.32%	7.73%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.3602 of 5 stars	$10.50 -2.1%	$13.54 +28.9%	-23.4%	$2.14B	$3.68B	N/A	14,000	Positive News
COO Cooper Companies	3.9322 of 5 stars	$70.09 -1.5%	$81.64 +16.5%	-19.9%	$13.88B	$4.09B	59.40	15,000	Trending News Earnings Report Analyst Forecast Buyback Announcement Gap Down
MMSI Merit Medical Systems	3.2731 of 5 stars	$90.66 +0.2%	$100.00 +10.3%	-2.6%	$5.40B	$1.52B	37.46	7,500	Positive News
NVST Envista	2.7595 of 5 stars	$27.13 flat	$29.31 +8.0%	+24.4%	$4.36B	$2.72B	46.78	12,000	Analyst Forecast
BLCO Bausch + Lomb	3.3791 of 5 stars	$17.46 +1.8%	$18.75 +7.4%	+16.9%	$6.13B	$5.10B	N/A	13,000	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, BLCO, and ICUI

How does DENTSPLY SIRONA compare to Cooper Companies?

Which has more volatility and risk, COO or XRAY?

Is COO or XRAY more profitable?

Do insiders and institutionals believe in COO or XRAY?

Does the media refer more to COO or XRAY?

Do analysts prefer COO or XRAY?

Which has better earnings & valuation, COO or XRAY?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Which has stronger valuation & earnings, XRAY or MMSI?

Do analysts rate XRAY or MMSI?

Do insiders & institutionals hold more shares of XRAY or MMSI?

Which has more risk & volatility, XRAY or MMSI?

Does the media favor XRAY or MMSI?

Is XRAY or MMSI more profitable?

Summary

How does DENTSPLY SIRONA compare to Envista?

Which has more risk & volatility, XRAY or NVST?

Which has better earnings & valuation, XRAY or NVST?

Does the media refer more to XRAY or NVST?

Is XRAY or NVST more profitable?

Do insiders & institutionals believe in XRAY or NVST?

Do analysts recommend XRAY or NVST?

Summary

How does DENTSPLY SIRONA compare to Bausch + Lomb?

Which has higher earnings & valuation, BLCO or XRAY?

Do institutionals & insiders have more ownership in BLCO or XRAY?

Does the media refer more to BLCO or XRAY?

Do analysts prefer BLCO or XRAY?

Which has more risk and volatility, BLCO or XRAY?

Is BLCO or XRAY more profitable?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Do analysts prefer XRAY or ICUI?

Do institutionals & insiders hold more shares of XRAY or ICUI?

Does the media refer more to XRAY or ICUI?

Which has more risk and volatility, XRAY or ICUI?

Which has preferable earnings & valuation, XRAY or ICUI?

Is XRAY or ICUI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools